Table 3.
Indications | D1 | D2 | D3 | D4 | Total (%) |
---|---|---|---|---|---|
Respiratory tract infection | 382 | 316 | 1072 | 523 | 2293 (34.3) |
Gastrointestinal infection | 133 | 177 | 526 | 284 | 1120 (16.8) |
Skin and soft-tissue infection | 162 | 153 | 367 | 178 | 860 (12.9) |
Pre- or post-operative prophylaxis | 171 | 132 | 381 | 158 | 842 (12.6) |
COVID-19 | 158 | 117 | 363 | 170 | 808 (12.0) |
Urinary tract infection | 76 | 68 | 133 | 136 | 413 (6.2) |
Eye/ear infection | 36 | 24 | 118 | 41 | 219 (3.3) |
Others | 14 | 27 | 54 | 32 | 127 (1.9) |
NB: D1–D4 refer to the participating Divisions in the Region.